Glomerular Diseases in the Colombian Caribbean: Data from the Colombian Nephropathy Registry (NEFRORED®)

datacite.rightshttp://purl.org/coar/access_right/c_abf2spa
dc.contributor.authorAroca-Martínez, Gustavo
dc.contributor.authorGonzález-Torres, Henry J.
dc.contributor.authorDomínguez-Vargas, Alex
dc.contributor.authorGarcía- Tolosa, Raúl
dc.contributor.authorCastillo-Parodi, Luis
dc.contributor.authorConde-Manotas, Juan
dc.contributor.authorNavarro-Quiroz, Elkin
dc.contributor.authorAcuña- Freyte, Andersson
dc.contributor.authorDepine, Santos Ángel
dc.contributor.authorCadena-Bonfanti, Andrés
dc.contributor.authorMusso, Carlos G.
dc.date.accessioned2023-04-28T15:37:57Z
dc.date.available2023-04-28T15:37:57Z
dc.date.issued2022
dc.description.abstractOur study aimed to describe the glomerular diseases, both primary glomerular disease (PGD) and secondary glomerular disease (SGD) in the Colombian Caribbean based on the first regional Colombian Nephropathy Registry (NEFRORED®). A descriptive and retrospective study of adult patients with glomerular diseases from the Colombian Caribbean region was made. All diagnoses by renal biopsy with light microscopy and immunofluorescence obtained between January 2008 and June 2018 were recorded. Eight hundred and seventy-one renal biopsies were obtained. The main clinical indication for biopsy was nephritic syndrome (36%). SGD was more frequent than PGD (55% vs. 45%). Within SGD group, lupus nephritis (LN) was the most frequent etiology (83%). Within PGD group, membranous nephropathy (33%) and focal segmental glomerulosclerosis (FSGS) (19%) were the most common glomerular diseases. At a 24-month follow-up, the patients with FSGS and paraproteinemia-mediated glomerular disease had the worst renal survival prognosis. This is the first Colombian Nephropathy Registry in a Caribbean population, demonstrating a high predominance of SGD due to LN.eng
dc.format.mimetypepdfspa
dc.identifier.doiDOI: 10.4103/1319-2442.374379
dc.identifier.issn23203838
dc.identifier.issn13192442
dc.identifier.urihttps://hdl.handle.net/20.500.12442/12311
dc.identifier.urlhttps://journals.lww.com/sjkd/Fulltext/2022/33070/Glomerular_Diseases_in_the_Colombian_Caribbean_.3.aspxeng
dc.language.isoengeng
dc.publisherWolters Kluwereng
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacionaleng
dc.rights.accessrightsinfo:eu-repo/semantics/openAccessspa
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.sourceSaudi Journal of Kidney Diseases and Transplantationeng
dc.sourceSaudi J Kidney Dis Transpleng
dc.sourceVol 33 (Suppl. 1), (2022)
dc.titleGlomerular Diseases in the Colombian Caribbean: Data from the Colombian Nephropathy Registry (NEFRORED®)eng
dc.type.driverinfo:eu-repo/semantics/articleeng
dc.type.spaArtículo científicospa
dcterms.referencesO'Shaughnessy MM, Hogan SL, Thompson BD, Coppo R, Fogo AB, Jennette JC. Glomerular disease frequencies by race, sex and region: Results from the international kidney biopsy survey. Nephrol Dial Transplant 2018;33:661-9.eng
dcterms.referencesJohnson R, Feehally J, Floege J. Primary Glomerular Disease. Amsterdam. Elsevier Compr Clin Nephrol.2010;6: 193-207.eng
dcterms.referencesGolay V, Trivedi M, Abraham A, Roychowdhary A, Pandey R. The spectrum of glomerular diseases in a single Center: A clinicopathological correlation. Indian J Nephrol 2013;23:168-75.eng
dcterms.referencesKasamatsu E, Nunes VM, Morán M, Centurión M, Campos de Alvarenga S. Glomerulopathies in paraguay. Report of registry of renal biopsies in 1072 cases. Mem Inst Investig Cienc Salud 2005;1:51-7.eng
dcterms.referencesCosta DM, Valente LM, Gouveia PA, et al. Comparative analysis of primary and secondary glomerulopathies in the northeast of Brazil: Data from the pernambuco registry of glomerulopathies – REPEG. J Bras Nefrol 2017;39:29-35.eng
dcterms.referencesSimon P, Ramee MP, Boulahrouz R, et al. Epidemiologic data of primary glomerular diseases in Western France. Kidney Int 2004;66:905-8.eng
dcterms.referencesChang JH, Kim DK, Kim HW, et al. Changing prevalence of glomerular diseases in Korean adults: A review of 20 years of experience. Nephrol Dial Transplant 2009;24:2406-10.eng
dcterms.referencesMalafronte P, Mastroianni-Kirsztajn G, Betônico GN, et al. Paulista registry of glomerulonephritis: 5-year data report. Nephrol Dial Transplant 2006;21:3098-105.eng
dcterms.referencesRychlík I, Jancová E, Tesar V, et al. The Czech registry of renal biopsies. Occurrence of renal diseases in the years 1994-2000. Nephrol Dial Transplant 2004;19:3040-9.eng
dcterms.referencesCovic A, Schiller A, Volovat C, et al. Epidemiology of renal disease in Romania: A 10 year review of two regional renal biopsy databases. Oxford. Nephrol Dial Transplant 2006;21:419-24.eng
dcterms.referencesAroca-Martínez G, Depine S, Consuegra- Machado JR, González-Torres HJ, Árquez- Mendoza M, Estrada-García E. Development and use of an application programming interface modified from GoogleMaps© for the georeferencing of patients with glomerular disease. Nefrologia 2015;35: 118-20.eng
dcterms.referencesWeiskopf NG, Hripcsak G, Swaminathan S, Weng C. Defining and measuring completeness of electronic health records for secondary use. J Biomed Inform 2013;46:830-6.eng
dcterms.referencesRivera Gorrin M. Ultrasound-guided renal biopsy. Nefrologia 2010;30:490-2.eng
dcterms.referencesKDIGO Clinical Practice Guideline for Glomerulonephritis KDIGO Clinical Practice Guideline for Glomerulonephritis KDIGO Clinical Practice Guideline for Glomerulonephritis. Kidney supplements. 2012;3(1): 1- 150eng
dcterms.referencesSethi S, Haas M, Markowitz GS, et al. Mayo clinic/renal pathology society consensus report on pathologic classification, diagnosis, and reporting of GN. J Am Soc Nephrol 2016;27: 1278-87.eng
dcterms.referencesMarkowitz GS, D'Agati VD. The ISN/RPS 2003 classification of lupus nephritis: An assessment at 3 years. Kidney Int 2007;71:491- 5.eng
dcterms.referencesVerde E, Quiroga B, Rivera F, López-Gómez JM. Renal biopsy in very elderly patients: Data from the Spanish registry of glomerulonephritis. Am J Nephrol 2012;35:230-7.eng
dcterms.referencesLópez-Gómez JM, Rivera F, Spanish Registry of Glomerulonephritis. Renal biopsy findings in acute renal failure in the cohort of patients in the Spanish registry of glomerulonephritis. Clin J Am Soc Nephrol 2008;3:674-81.eng
dcterms.referencesKellum J, Lameire N, Aspelin P, et al. Kidney disease: Improving global outcomes (KDIGO) acute kidney injury work group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl 2012;2:17.eng
dcterms.referencesNational Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classifi-cation, and stratification. Am J Kidney Dis 2002;39:S1-266.eng
dcterms.referencesRosenberg AZ, Kopp JB. Focal segmental glomerulosclerosis. Clin J Am Soc Nephrol 2017;12:502-17.eng
dcterms.referencesSethi S, Fervenza FC. Membrano-proliferative glomerulonephritis – A new look at an old entity. N Engl J Med 2012;366:1119-31.eng
dcterms.referencesCouser WG. Primary membranous nephropathy. Clin J Am Soc Nephrol 2017;12:983-97.eng
dcterms.referencesMalik GH, Al-Mohaya S, Shaikh JF, et al. Repeated pregnancies in patients with nonimmunoglobulin a mesangio-proliferative glomerulonephritis. Am J Nephrol 2001;21:378- 82.eng
dcterms.referencesVizjak A, Ferluga D, Rozic M, et al. Pathology, clinical presentations, and outcomes of C1q nephropathy. J Am Soc Nephrol 2008;19:2237- 44.eng
dcterms.referencesRavindran A, Fervenza FC, Smith RJH, De Vriese AS, Sethi S. C3 glome-rulopathy: Ten years' experience at mayo clinic. Mayo Clin Proc 2018;93: 991-1008.eng
dcterms.referencesD'Agati VD, Fogo AB, Bruijn JA, Jennette JC. Pathologic classification of focal segmental glomerulosclerosis: A working proposal. Am J Kidney Dis 2004;43:368-82.eng
dcterms.referencesR Core Team. R. A language and environment for statistical computing. Computer Science 2015;1:1-3873eng
dcterms.referencesGesualdo L, Di Palma AM, Morrone LF, Strippoli GF, Schena FP, Italian Immunopathology Group, Italian Society of Nephrology. The Italian experience of the national registry of renal biopsies. Kidney Int 2004;66:890-4.eng
dcterms.referencesLi LS, Liu ZH. Epidemiologic data of renal diseases from a single unit in China: Analysis based on 13,519 renal biopsies. Kidney Int 2004;66:920-3.eng
dcterms.referencesMazzuchi N, Acosta N, Caorsi H, et al. Frequency of diagnosis and clinic presentation of glomerulopathies in Uruguay. Nefrologia 2005;25:113-20.eng
dcterms.referencesNaumovic R, Pavlovic S, Stojkovic D, Basta- Jovanovic G, Nesic V. Renal biopsy registry from a single centre in Serbia: 20 years of experience. Nephrol Dial Transplant 2009;24:877-85.eng
dcterms.referencesPolito MG, de Moura LA, Kirsztajn GM. An overview on frequency of renal biopsy diagnosis in Brazil: Clinical and pathological patterns based on 9,617 native kidney biopsies. Nephrol Dial Transplant 2010;25:490-6.eng
dcterms.referencesFloege J, Amann K. Primary glomerulonephritides. Lancet 2016;387:2036-48.eng
dcterms.referencesOssareh S, Asgari M, Abdi E, et al. Renal biopsy findings in Iran: Case series report from a referral kidney Center. Int Urol Nephrol 2010;42:1031-40.eng
dcterms.referencesSwaminathan S, Leung N, Lager DJ, et al. Changing incidence of glomerular disease in Olmsted County, Minnesota: A 30-year renal biopsy study. Clin J Am Soc Nephrol 2006;1:483-7.eng
dcterms.referencesConde Olasagasti JL, Acevedo Ribó M, Roca Muñoz A, et al. Estudio evolutivo de las glomerulonefritis en Castilla-La Mancha (GLOMANCHA) en el periodo 1994-2008. Nefrologia 2016;36:237-42.eng
dcterms.referencesChávez Valencia V, Orizaga de La Cruz C, Guillermo Becerra Fuentes J, et al. Epidemiología de la enfermedad glomerular en adultos. Revisión de una base de datos. Gac Med Mex 2014;150:403-8.eng
dcterms.referencesArias LF, Henao J, Giraldo RD, Carvajal N, Rodelo J, Arbeláez M. Glomerular diseases in a Hispanic population: Review of a regional renal biopsy database. Sao Paulo Med J 2009;127:140-4.eng
dcterms.referencesPiccoli GB, Daidola G, Attini R, et al. Kidney biopsy in pregnancy: Evidence for counselling? A systematic narrative review. BJOG 2013;120:412-27.eng
dcterms.referencesBonett O. Factores predictores de respuesta a tratamiento de nefritis lúpica en pacientes adultos biopsiados en la clínica de la costa de Barranquilla (Atlántico-Colombia) Durante el período 2008-2014 predictors of response to treatment of nephritis adults in lup. Biociencias 2015;10:107-17.spa
dcterms.referencesPinto L, Castro I, Duque V, Márquez J, Velásquez C. Factores de riesgo predictores de falla a la terapia de inducción de nefritis lupica en una cohorte de pacientes colombianos. Reumatol Clin 2014;10:147-51.spa
dcterms.referencesArroyo A, García R, Aroca G, Acosta J. Correlación clínica e inmunohistopatológica de la nefropatía lúpica en un centro de referencia del Caribe colombiano durante los años 2012 a 2013. Rev Colomb Nefrol 2014;1:57-64.spa
dcterms.referencesSandoval C, De la Hoz A, Yunis E. Estructura Genetica de la Poblacion Colombiana. Rev Fac Med 1993;41:3-14.eng
dcterms.referencesWade P, Beltrán C, Restrepo E, Ventura R. Mestizo Genomics: Race Mixture, Nation, and Science in Latin America. Durham. Duke University Press. 2014.eng
dcterms.referencesRivera F, López-Gómez JM, Pérez-García R, Spanish Registry of Glomerulonephritis. Clinicopathologic correlations of renal pathology in Spain. Kidney Int 2004;66:898- 904.eng
dcterms.referencesKwon YE, Han SH, Kie JH, et al. Clinical features and outcomes of focal segmental glomerulosclerosis pathologic variants in Korean adult patients. BMC Nephrol 2014;15:52.eng
dcterms.referencesCouchoud C, Pozet N, Labeeuw M, Pouteil- Noble C. Screening early renal failure: Cut-off values for serum creatinine as an indicator of renal impairment. Kidney Int 1999;55:1878-84.eng
dcterms.referencesCusumano AM, González Bedat MC. Chronic kidney disease in Latin America: Time to improve screening and detection. Clin J Am Soc Nephrol 2008;3:594-600.eng
dcterms.referencesLevey AS, Atkins R, Coresh J, et al. Chronic kidney disease as a global public health problem: Approaches and initiatives – A position statement from kidney disease improving global outcomes. Kidney Int 2007; 72:247-59.eng
oaire.versioninfo:eu-repo/semantics/publishedVersionspa

Archivos

Bloque original
Mostrando 1 - 1 de 1
Cargando...
Miniatura
Nombre:
PDF.pdf
Tamaño:
287.55 KB
Formato:
Adobe Portable Document Format
Descripción:
PDF
Bloque de licencias
Mostrando 1 - 1 de 1
No hay miniatura disponible
Nombre:
license.txt
Tamaño:
381 B
Formato:
Item-specific license agreed upon to submission
Descripción:

Colecciones